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OBJECTIVE: A number of recent studies suggest that leptin has effects on glucose metabolism and pancreatic
hormone secretion. Therefore, the effect of leptin administration on circulating glucose, insulin and glucagon in fed
and fasted mice was investigated. The potential contribution of the sympathetic nervous system to the effects of
leptin was also examined.
DESIGN: Recombinant human or murine leptin was administered intraperitoneally (300 mg=mouse per 12 h over 24 h)
to fed or fasted, normal or chemically sympathectomized NMRI mice. Blood samples were collected at baseline and
after 24 h.
MEASUREMENTS: Plasma concentrations of glucose, insulin and glucagon.
RESULTS: In the fed state (n 24), leptin administration did not affect glucose, insulin or glucagon concentrations
after 24 h. Fasting (n 24) reduced body weight by 2.20.4 g, plasma glucose by 3.70.4 mmol=l, plasma insulin by
13835 pmol=l, and plasma glucagon by 327 pg=ml. In fasted mice, human leptin (n 24) increased plasma glucose
by 1.50.2 mmol=l (P 0.041), plasma insulin by 9522 pmol=l (P 0.018), and plasma glucagon by 163 pg=ml
(P 0.025), relative to saline-injected control animals. Murine leptin exerted similar stimulating effects on circulating
glucose ( 1.00.2 mmol=l, P 0.046), insulin ( 5817 pmol=l, P 0.038) and glucagon ( 249 pg=ml, P 0.018) as
human leptin in fasted mice (n 12) with no significant effect in fed mice (n 12). Human leptin did not affect
circulating glucose, insulin or glucagon in fasted mice after chemical sympathectomy with 6-hydroxydopamine
(40 mg=kg iv 48 h prior to fasting; n 12).
CONCLUSION: Leptin increases circulating glucose, insulin and glucagon in 24 h fasted mice by a mechanism requiring
intact sympathetic nerves.
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Introduction
Leptin is released from the adipocytes in relation to
body fat content and recent energy balance.1 – 4 Leptin
administration inhibits food intake and increases the
energy expenditure resulting in reduction in body
weight.1 – 4 Leptin gene transfection5 or continuous
leptin infusion6 leads to marked loss of adipose
stores. Leptin has also been demonstrated to exhibit
metabolic actions. Studies in ob=ob mice have demon-
strated reductions of circulating glucose and insulin in
response to leptin administration that are independent
of the reduction in food intake.7 Circulating leptin
concentrations are decreased by fasting8 – 10 or energy
restriction11 and increase rapidly after refeeding.10
The changes of leptin production during positive and
negative energy balance may be mediated by insulin-
induced alterations of adipocyte glucose uptake and
metabolism.12,13 Administration of leptin during 48 h
fasting in mice has been shown to attenuate the
fasting-induced changes in glucocorticoids and thyr-
oid hormones.8 Hence, it is possible that leptin pro-
vides the brain with a signal of sufficient peripheral
energy reserves, and when these reserves are insuffi-
cient, lowered leptin concentrations are a signal that
initiates neuroendocrine responses to restore energy
balance. The autonomic nervous system may be
involved in mediation of these responses; recent
studies suggest that leptin activates the sympathetic
nervous system.14 – 16
In the present study, we investigated the effects of
pharmacological doses of recombinant human and
murine leptin on the changes of plasma glucose and
the pancreatic hormones, insulin and glucagon during
fasting in mice. To determine whether activation of
the sympathetic nerves may be involved in the
observed effects, we also examined the influence of
leptin on glucose, insulin and glucagon responses to
fasting in mice treated with 6-hydroxy-dopamine (6-
OHDA), inducing selective chemical sympathect-
omy.17 Pancreatic islets of mice treated with 6-
OHDA are devoid of sympathetic innervation at 48 h
after administration of 6-OHDA as evident by
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fluorescent demonstration of catecholamines18 and
immunohistochemical visualization of the noradrener-
gic nerve marker, tyrosine hydroxylase.19
Methods
Animals
NMRI mice (Bomholdtgaard Breeding and Research
Center, Ry, Denmark), weighing 24 – 27 g were used.
The animals were fed a standard pellet diet (Lactamin
AB, Stockholm, Sweden) and tap water ad libitum.
Experiments
In the first experimental series, a baseline blood
sample (250ml) was taken from the retrobulbar
intraorbital capillary plexus. The mice were then
either fasted on grids or had free access to their
normal food for 24 h. Two intraperitoneal injections
of either saline or recombinant human or murine
leptin (Amgen Inc., Thousand Oaks, CA) were given
at a dose of 300 mg per mouse (volume 250 ml=mouse).
The first injection was administered immediately after
the initial blood sample was collected and the second
was given 12 h later. After 24 h, a second blood
sample was taken. Body weight was determined
before the initial and final blood sample. In a second
experimental series, mice were injected intravenously
via the tail vein with 6-OHDA hydrochloride
(40 mg=kg dissolved in 10 mg=ml ascorbic acid;
Sigma Chemical Co, St Louis, Mo, USA; volume
250 ml) or vehicle. Two days later, the mice were
subjected to the protocol as described above.
Analysis
Plasma insulin was determined radioimmunochemi-
cally with the use of a guinea pig anti-rat insulin
antibody, 125I-labelled human insulin as tracer and rat
insulin as standard (Linco Research, St. Charles, MO,
USA). Free and bound radioactivity was separated by
use of an anti-IgG (goat anti-guinea pig) antibody
(Linco). The sensitivity of the assay is 12 pmol=l and
the coefficient of variation is less than 3%. Plasma
glucagon was determined radioimmunochemically
with the use of a guinea pig antiglucagon antibody
specific for pancreatic glucagon, 125I-labelled-gluca-
gon as tracer, and glucagon standard (Linco). Free and
bound radioactivity were separated by use of an anti-
IgG (goat anti-guinea pig) antibody (Linco). The
sensitivity of the assay is 7.5 pg=ml and the coefficient
of variation is less than 9%. Plasma glucose was
determined with the glucose oxidase method.
Statistics
Data are presented as means sem. Statistical ana-
lyses were performed with the SPSS for Windows
system. Statistical comparisons for the differences
between the different groups of mice within each
experimental series were performed by ANOVA
with Bonferroni post-hoc analysis.
Results
Effects of human leptin in fed and fasted normal mice
During 24 h fasting (n 24), body weight, plasma
glucose, plasma insulin and plasma glucagon were
all reduced, whereas in the fed controls (n 24), these
parameters did not change significantly during the
24 h study period. In the fed state, leptin administra-
tion (n 24) did not significantly alter circulating
levels of glucose, insulin or glucagon. In contrast, in
fasting animals, leptin administration (n 24)
increased circulating levels of glucose, insulin and
glucagon. Figure 1 illustrates the reduction in the
parameters in fasting animals with or without admin-
istration of leptin. Human leptin attenuated the fast-
ing-induced reductions of glucose (by 49%), insulin
(by 74%), and glucagon (by 97%). (see Table 1,
Figure 1.)
Figure 1 Changes in body weight (A) and plasma levels of
glucose (B), insulin (C) and glucagon (D) after 24 h fasting in
normal or chemically sympathectomized mice without or with
administration of recombinant human leptin (2300mg=mouse).
Chemical sympathectomy was induced by 6-OHDA (40 mg=kg)
given 48 h before the experiments. MeansSEM are shown.
Asterisks indicate probability level of random difference
between the groups. *P<0.05. There were 24 animals in each
group of normal mice and 12 animals in each group of sym-
pathectomized mice.
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Effects of murine leptin in fed and fasted normal mice
Similar to human leptin, murine leptin did not affect
plasma glucose, insulin or glucagon after 24 h in the
fed state (n 12), whereas administration of murine
leptin during the fasting period (n 12) increased
circulating concentrations of glucose, insulin and
glucagon relative to saline-treated control mice
(n 12). Therefore, murine leptin attenuated the fast-
ing-induced reductions of glucose (by 25%), insulin
(by 56%), and glucagon (by 82%) (see Table 2).
Fed and fasted chemically sympathectomized mice
In chemically sympathectomized mice, body weight
as well as plasma glucose, insulin and glucagon were
reduced by 24 h fasting (n 12), whereas in continu-
ously fed mice, these parameters were unchanged
(n 12). Administration of human leptin did not
significantly affect glucose, insulin, or glucagon in
sympathectomized mice either under fasting (n 12)
or fed (n 12) conditions. Figure 1 illustrates the
reduction in the parameters in sympathectomized
fasting animals with or without administration of
leptin. It is seen that human leptin did not affect the
fasting-induced reduction in glucose, insulin or glu-
cagon (see also Table 3).
Discussion
Leptin is produced in the adipocyte in relation to the
degree of adiposity and recent energy balance. Leptin
acts in the brain to inhibit food intake and increase
energy expenditure, and thus may provide a negative
feedback signal to restrict energy storage.1,20 Leptin is
likely to be of importance in times of insufficient
energy reserves, such as fasting or starvation.4,8
During fasting, circulating leptin concentrations
Table 1 Body weight and plasma levels of glucose, insulin and glucagon before and after 24 h in mice subjected
to fasting or continuous feeding with or without administration of recombinant human leptin (300mg i.p.)
administered after the initial blood sampling and after 12 h
Fedmice Fedmice Fastedmice Fastedmice
given saline given human given saline given human
(n24) leptin (n24) (n24) leptin (n24)
Body weight (g)
Initial 27.5 0.8 27.8 1.1 27.3 0.9 26.9 1.0
After 24 h 27.6 0.7 27.0 1.1 25.1 0.6** 24.6 0.9**
Plasma glucose (mmol=l)
Initial 7.8 0.2 8.20.2 8.0 0.3 8.0 0.2
After 24 h 8.1 0.2 8.50.2 4.3 0.3** 5.8 0.3**a
Plasma insulin (pmol=l)
Initial 151 21 204 37 214 39 208 13
After 24 h 213 31 196 36 76 16** 171 11**a
Plasma glucagon (pg=ml)
Initial 54 5 54 6 63 7 50 6
After 24 h 70 6 73 9 31 3* 47 4a
Asterisks indicate probability level of random difference between the initial sample and that taken at 24 h by means
of ANOVA with Bonferroni post-hoc analysis, *P<0.05, **P<0.01. aindicates probability level of random difference
between fasted animals given saline vs fasted animals given human leptin of P<0.05.
MeansSEM are shown.
Table 2 Body weight and plasma levels of glucose, insulin and glucagon before and after 24 h in mice subjected
to fasting or continuous feeding with or without administration of recombinant murine leptin (300mg i.p.)
administered after the initial blood sampling and after 12 h
Fedmice given Fastedmice Fastedmice
Fedmice given murine leptin given saline givenmurine
saline (n12) (n12) (n12) leptin (n12)
Body weight (g)
Initial 29.10.4 29.50.3 28.20.9 28.5 1.0
After 24 h 28.90.3 28.90.3 24.90.8** 25.0 0.7**
Plasma glucose (mmol=l)
Initial 8.90.2 8.70.2 7.70.4 7.9 0.2
After 24 h 9.10.3 9.10.2 4.60.4** 5.6 0.2**
Plasma insulin (pmol=l)
Initial 20123 24859 19328 196 38
After 24 h 23333 19421 10626** 162 26a
Plasma glucagon (pg=ml)
Initial 865 795 6511 70 12
After 24 h 835 884 425* 66 10a
Asterisks indicate probability level of random difference between the initial sample and that taken at 24 h means of
ANOVA with Bonferroni post-hoc analysis, *P<0.05, **P<0.01. aindicates probability level of random difference
between fasted animals given saline vs fasted animals given human leptin of P<0.05.
MeansSEM are shown.
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fall8,9 and a series of neuroendocrine responses are
initiated, including stimulation of glucocorticoid
secretion and inhibition of thyroid hormone secre-
tion.8 Therefore, one function of leptin might be to
provide the brain with information of sufficient peri-
pheral energy stores and recent energy balance,
whereas low leptin concentrations provide a signal
of decreasing food intake and energy stores. The most
pronounced effects of exogenously administered
leptin would therefore by anticipated in the fasted
state.
In the previous study by Ahima et al,8 leptin was
found to attenuate the effects of fasting on glucocor-
ticoid, thyroid and reproductive hormones in mice, but
did not influence the fasting-induced reductions of
circulating glucose and insulin. In that study, leptin
was administered at a lower dose (21 mg=g daily)
than in the present study, in which, an approximately
tenfold higher dose (210mg=g) of leptin increased
circulating glucose, insulin and glucagon during fast-
ing. In contrast, concentrations of glucose, insulin and
glucagon were unaffected by this dose of leptin in the
fed state. These results suggest that plasma levels of
glucose and two islet hormones are more readily
increased by leptin during fasting than in the fed
state, and that pharmacological doses appear to be
required in order to observe these effects.
A previous study in normal mice has shown that
leptin at high doses slightly reduces circulating glu-
cose without altering plasma insulin,21 and another
study has shown that leptin increases glucose turnover
without altering the basal concentrations of glucose or
insulin.22 In markedly glucose intolerant ob=ob mice,
leptin reduces plasma glucose and insulin.7 Elevations
of plasma leptin in rats resulting from either 48 h
continuous subcutaneous infusion of a low dose of
leptin23 or 14 d after transfecting the livers of rats with
an adenovirus expressing the rat leptin cDNA24
lowered glucose and insulin concentrations. Other
studies have shown no change in circulating glucose
but markedly reduced plasma insulin after infusing
leptin in rats for 3 h14 or after marked elevation of
leptin for 28 d.5 Together, these results are consistent
with an effect of leptin to increase insulin sensitivity,
as has recently been demonstrated in rats by using
euglycaemic, hyperinsulinaemic clamp techniques.6,25
Our results differ from these findings in that no
changes of plasma glucose or insulin were observed
after leptin administration in the fed state; and in the
fasted state, leptin increased circulating glucose and
insulin relative to saline-injected animals. Therefore,
in the present study, pharmacological doses of leptin
do not appear to enhance insulin sensitivity, particu-
larly during fasting. Recent results from a similar
experiment with high dose leptin administration in
rhesus monkeys have shown that leptin increased
fasting plasma glucose without altering circulating
insulin concentrations.26
A major finding in the present study was that leptin
did not significantly affect circulating glucose, insulin
and glucagon in the 24 h fasted mice that were pre-
treated with 6-OHDA. Although in this study, we did
not perform tissue catecholamine measurements or
histology for sympathetic nerves in the mice, 6-
OHDA at the same dose level (40 mg=kg) produces
marked reductions of tissue noradrenaline and
decreases the number of tyrosine hydroxylase contain-
ing nerves.18,19 Furthermore, 6-OHDA is known to
produce a selective chemical sympathectomy at the
level of post-ganglionic nerve terminals and does not
affect the adrenal medulla.17,18,19 Therefore, our
results suggest that intact sympathetic innervation is
required for the gluco-regulatory actions of leptin
during fasting. In addition, circulating adrenaline
could contribute to the failure of leptin to increase
plasma insulin in fasted 6-OHDA treated animals,
Table 3 Body weight and plasma levels of glucose, insulin and glucagon before and after 24 h in chemically
sympathectomized mice subjected to fasting or continuous feeding with or without administration of human leptin
(300mg i.p.) administered after the first blood sampling and after 12 h. The mice had been chemically
sympathectomized 48 h before the initial blood sampling by means of i.v. administration of 6-hydroxydopamine
(40 mg=kg)
Fedmice given Fastedmice Fastedmice
Fedmice given human leptin given saline given human
saline (n12) (n12) (n12) leptin (n12)
Body weight (g)
Initial 29.5 0.5 30.50.7 30.5 0.5 30.2 0.3
After 24 h 29.6 0.6 30.50.6 27.5 0.6** 27.5 0.3**
Plasma glucose (mmol=l)
Initial 7.5 0.3 7.50.2 7.9 0.2 7.6 0.3
After 24 h 8.2 0.5 7.40.1 3.9 0.2** 3.8 0.3***
Plasma insulin (pmol=l)
Initial 199 19 18423 174 21 201 23
After 24 h 201 11 17619 81 20** 71 21**
Plasma glucagon (pg=ml)
Initial 65 8 7410 65 10 60 8
After 24 h 72 10 6311 11 12** 15 13**
Asterisks indicate probability level of random difference between the initial sample and that taken at 24 h by means
of ANOVA with Bonferroni post-hoc analysis, *P< 0.05, **P< 0.01, ***P< 0.001.
MeanSEM are shown.
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because leptin15,27 and fasting28 can both increase
adrenal medullary activity as might a compensatory
increase after 6-OHDA.29 These would all tend to
increase circulating adrenaline, which is known to
inhibit insulin secretion.30
It has previously been reported that leptin activates
the activity of the sympathetic nerves, determined as
increased noradrenaline turnover in brown adipose
tissue16 and increased firing rates of sympathetic
nerves in several tissues.14,15 Such a stimulatory
action of leptin on sympathetic nerve activity could
explain the increases of glucose and glucagon we
observed during fasting, since sympathetic nerve
activation stimulates hepatic glucose production and
glucagon secretion.30,31 Similarly, it has recently been
reported that pharmacological a- and b-adrenergic
blockade prevents the increases of circulating glucose,
lactate, and glucagon induced by leptin in rhesus
monkeys,26 demonstrating a role for the sympathetic
nervous system in mediating the metabolic effects of
leptin administration. However, such an action would
not explain the increase of circulating insulin, since
sympathetic nerve activation is known to inhibit
insulin secretion.30 It is possible that the leptin-
induced increase of plasma insulin observed in the
present study occurs as an indirect response to sym-
pathetic activation, perhaps in conjunction with adre-
naline released from the adrenal medulla.32,33 This
would stimulate glucagon secretion and increase
hepatic glucose production,35 resulting in increased
circulating glucose and glucagon, which in turn sti-
mulate insulin secretion.
A direct stimulatory action of leptin could also
contribute to the increased hepatic glucose production
and insulin secretion since leptin receptors are
expressed in the liver and on pancreatic b-cells.36,37
However, such a direct effect is unlikely since the
changes of glucose and pancreatic hormones were
prevented by sympathectomy with 6-OHDA. Further-
more, this latter explanation is also less likely with
regard to the observed increased plasma insulin,
because most reports have shown an inhibitory influ-
ence of leptin on pancreatic insulin secretion.38 – 41
The reduction in circulating glucagon after 24 h
fasting is consistent with the reduction in circulating
glucose, since glucagon contributes to glucose pro-
duction during fasting.35 The observed reduction of
plasma glucagon after 24 h fasting is, however, at
variance with a previous study in which we observed
a 22% increase in plasma glucagon after overnight
fasting in mice in conjunction with similar level of
glycaemia as in the present study.42 The glucagon
response to fasting is not well understood because
both increased,43 decreased44,45 and unaffected46
levels have been reported in humans. Whether these
discrepancies in glucagon responses to energy restric-
tion result from different lengths of fasting, different
antibodies for the determination of glucagon (some
antibodies cross react with immunoglobulins,47) or
other conditions, deserves to be studied in more detail.
Conclusion
Our present results demonstrate that pharmacological
doses of leptin increase circulating glucose, insulin
and glucagon in fasted, but not in fed, mice. These
effects are prevented by chemical sympathectomy
induced by administration of 6-OHDA, suggesting
that changes in circulating glucose, insulin and glu-
cagon induced by leptin administration during fasting
require an intact sympathetic nervous system.
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